Zoetis (ZTS) Invested Capital (2012 - 2025)
Zoetis' (ZTS) quarterly Invested Capital came in at $1.4 billion in Q2 2025, little changed on a QoQ basis from $1.4 billion in Q1 2025.
Zoetis (ZTS) Invested Capital (2012 - 2025) Analysis & Trends
Zoetis (ZTS) has 12 years of Invested Capital data on file, last reported at $1.4 billion in Q2 2025.
- On a quarterly basis, Invested Capital changed N/A year-over-year to $1.4 billion in Q2 2025; TTM through Mar 2026 was $1.4 billion, a 50.0% decrease from a year earlier, with the FY2024 full-year figure at $1.4 billion, changed N/A from the prior year.
- Invested Capital for Q2 2025 stood at $1.4 billion, roughly flat from $1.4 billion in the prior quarter.
- Over the last five years, Invested Capital for ZTS reached as high as $1.4 billion in Q1 2022 and fell as low as $2.0 million in Q2 2022.
- Historically, Invested Capital has averaged $553.0 million across 5 years, with a median of $312.0 million in 2021.
- Across the five-year window, Invested Capital tumbled 99.78% in 2023 and soared 5525.0% in 2025, its largest moves.
- Year by year, Invested Capital stood at $600.0 million in 2021, then tumbled by 99.67% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then surged by 67400.0% to $1.4 billion in 2024, then changed by 0.0% to $1.4 billion in 2025.
- Per Business Quant data, the three most recent Invested Capital figures were $1.4 billion in Q2 2025, $1.4 billion in Q1 2025, and $1.4 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.35 Bn |
| Mar 31, 2025 | 1.35 Bn |
| Dec 31, 2024 | 1.35 Bn |
| Mar 31, 2024 | 24.00 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 1.35 Bn |
| Jun 30, 2021 | 600.00 Mn |
| Mar 31, 2021 | 600.00 Mn |
| Dec 31, 2020 | 600.00 Mn |
| Sep 30, 2020 | 1.10 Bn |
| Jun 30, 2020 | 500.00 Mn |
| Mar 31, 2020 | 500.00 Mn |
| Oct 1, 2017 | 750.00 Mn |
| Jul 2, 2017 | 100.00 Mn |
| Apr 2, 2017 | 750.00 Mn |
| Apr 3, 2016 | 4.00 Mn |